TY - JOUR AU - Heijde, D. M. AU - Hof, M. A. AU - Riel, P. L. PY - 1992 DA - 1992// TI - Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis JO - Ann Rheum Dis VL - 51 UR - https://doi.org/10.1136/ard.51.2.177 DO - 10.1136/ard.51.2.177 ID - Heijde1992 ER - TY - JOUR AU - Felson, D. T. AU - Anderson, J. J. AU - Boers, M. PY - 1995 DA - 1995// TI - American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380602 DO - 10.1002/art.1780380602 ID - Felson1995 ER - TY - JOUR AU - Smolen, J. S. AU - Breedveld, F. C. AU - Schiff, M. H. PY - 2003 DA - 2003// TI - A simplified disease activity index for rheumatoid arthritis for use in clinical practice JO - Rheumatology (Oxford) VL - 42 UR - https://doi.org/10.1093/rheumatology/keg072 DO - 10.1093/rheumatology/keg072 ID - Smolen2003 ER - TY - JOUR AU - Aletaha, D. AU - Nell, V. P. AU - Stamm, T. PY - 2005 DA - 2005// TI - Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score JO - Arthritis Res Ther VL - 7 UR - https://doi.org/10.1186/ar1740 DO - 10.1186/ar1740 ID - Aletaha2005 ER - TY - JOUR AU - Prevoo, M. L. AU - van 't Hof, M. A. AU - Kuper, H. H. PY - 1995 DA - 1995// TI - Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380107 DO - 10.1002/art.1780380107 ID - Prevoo1995 ER - TY - JOUR AU - Smolen, J. S. AU - Breedveld, F. C. AU - Burmester, G. R. PY - 2016 DA - 2016// TI - Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207524 DO - 10.1136/annrheumdis-2015-207524 ID - Smolen2016 ER - TY - JOUR AU - Felson, D. T. AU - Smolen, J. S. AU - Wells, G. PY - 2011 DA - 2011// TI - American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2011.149765 DO - 10.1136/ard.2011.149765 ID - Felson2011 ER - TY - JOUR AU - Mäkinen, H. AU - Kautiainen, H. AU - Hannonen, P. PY - 2005 DA - 2005// TI - Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2005.037333 DO - 10.1136/ard.2005.037333 ID - Mäkinen2005 ER - TY - JOUR AU - Heijde, D. M. AU - Klareskog, L. AU - Boers, M. PY - 2005 DA - 2005// TI - Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2004.034371 DO - 10.1136/ard.2004.034371 ID - Heijde2005 ER - TY - JOUR AU - Smolen, J. S. AU - Aletaha, D. AU - Gruben, D. PY - 2016 DA - 2016// TI - Remission Rates with Tofacitinib Treatment in rheumatoid arthritis: a comparison of various remission criteria JO - Arthritis Rheum ID - Smolen2016 ER - TY - JOUR AU - Inoue, M. AU - Yamanaka, H. AU - Hara, M. PY - 2007 DA - 2007// TI - Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28 C-reactive protein threshold values JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.054205 DO - 10.1136/ard.2006.054205 ID - Inoue2007 ER - TY - JOUR AU - Castrejon, I. AU - Ortiz, A. M. AU - Toledano, E. PY - 2010 DA - 2010// TI - Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis JO - J Rheumatol VL - 37 UR - https://doi.org/10.3899/jrheum.091333 DO - 10.3899/jrheum.091333 ID - Castrejon2010 ER - TY - JOUR AU - Fleischmann, R. AU - Heijde, D. AU - Koenig, A. S. PY - 2015 DA - 2015// TI - How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204920 DO - 10.1136/annrheumdis-2013-204920 ID - Fleischmann2015 ER - TY - JOUR AU - Fleischmann, R. AU - Halland, A. M. AU - Brzosko, M. PY - 2013 DA - 2013// TI - Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results JO - J Rheumatol VL - 40 UR - https://doi.org/10.3899/jrheum.120447 DO - 10.3899/jrheum.120447 ID - Fleischmann2013 ER - TY - JOUR AU - Smolen, J. S. AU - Beaulieu, A. AU - Rubbert-Roth, A. PY - 2008 DA - 2008// TI - Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60453-5 DO - 10.1016/S0140-6736(08)60453-5 ID - Smolen2008 ER - TY - JOUR AU - Genovese, M. C. AU - McKay, J. D. AU - Nasonov, E. L. PY - 2008 DA - 2008// TI - Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the Tocilizumab in Combination With Traditional Disease-Modifying Anti-rheumatic Drug Therapy study JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23940 DO - 10.1002/art.23940 ID - Genovese2008 ER - TY - JOUR AU - Navarro-Compan, M. V. AU - Gherghe, A. M. AU - Smolen, J. S. PY - 2015 DA - 2015// TI - Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review JO - Rheumatology (Oxford) VL - 54 UR - https://doi.org/10.1093/rheumatology/keu413 DO - 10.1093/rheumatology/keu413 ID - Navarro-Compan2015 ER - TY - JOUR AU - Aletaha, D. AU - Machold, K. P. AU - Nell, V. P. PY - 2006 DA - 2006// TI - The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey JO - Rheumatology (Oxford) VL - 45 UR - https://doi.org/10.1093/rheumatology/kel074 DO - 10.1093/rheumatology/kel074 ID - Aletaha2006 ER - TY - JOUR AU - Balsa, A. AU - Miguel, E. AU - Castillo, C. PY - 2010 DA - 2010// TI - Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard JO - Rheumatology (Oxford) VL - 49 UR - https://doi.org/10.1093/rheumatology/kep442 DO - 10.1093/rheumatology/kep442 ID - Balsa2010 ER - TY - JOUR AU - Nishimoto, N. AU - Takagi, N. PY - 2010 DA - 2010// TI - Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study JO - Mod Rheumatol VL - 20 UR - https://doi.org/10.3109/s10165-010-0328-0 DO - 10.3109/s10165-010-0328-0 ID - Nishimoto2010 ER - TY - JOUR AU - Shaver, T. S. AU - Anderson, J. D. AU - Weidensaul, D. N. PY - 2008 DA - 2008// TI - The problem of rheumatoid arthritis disease activity and remission in clinical practice JO - J Rheumatol VL - 35 ID - Shaver2008 ER - TY - JOUR AU - Smolen, J. S. AU - Aletaha, D. AU - Gruben, D. PY - 2012 DA - 2012// TI - Remission rates with tofacitinib treatment in rheumatoid arthritis: a comparison of various remission criteria JO - Arthritis Rheum VL - 64 ID - Smolen2012 ER - TY - JOUR AU - Smolen, J. S. AU - Avila, J. C. AU - Aletaha, D. PY - 2012 DA - 2012// TI - Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/annrheumdis-2011-200395 DO - 10.1136/annrheumdis-2011-200395 ID - Smolen2012 ER - TY - JOUR AU - Aletaha, D. AU - Smolen, J. S. PY - 2011 DA - 2011// TI - Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30634 DO - 10.1002/art.30634 ID - Aletaha2011 ER -